<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Sphingomyelin decreases Colorectal cancer — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Sphingomyelin</strong>
  <span class="pred">&mdash;decreases&rarr;</span>
  <strong>Colorectal cancer</strong>
</div>
<div class="entity-id">CHEBI:17636 &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:0%;--color:#d62728"></div>
<div class="stat-row">
  <span>Class: Text Derived (0.01)</span>
  <span>Replicated: 3 papers</span>
  <span>Score: 3.12<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; DB Ref 0.5 &middot; Text Derived 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts &minus;0.5). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.02 (Text Derived, 3 papers)<br>Score from 24 citations: <strong>3.12</strong><br><span style="color:#888">2&times; extends (+1.55) &middot; 9&times; supports (+5.29) &middot; 13&times; contradicts (-3.73)</span><br>Neighbourhood: 7.54</div>


<p class="section-label">EVIDENCE CHAIN &middot; 3 sources</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#d62728" title="Text Derived"></span><span>Text Derived</span><a href="https://doi.org/10.1002/cncr.30829">10.1002/cncr.30829</a></div>
<div class="evidence-row"><span class="evidence-dot" style="background:#d62728" title="Text Derived"></span><span>Text Derived</span><a href="https://doi.org/10.1097/SLA.0000000000005164">10.1097/SLA.0000000000005164</a></div>
<div class="evidence-row"><span class="evidence-dot" style="background:#d62728" title="Text Derived"></span><span>Text Derived</span><a href="https://doi.org/10.1136/gutjnl-2024-332535">10.1136/gutjnl-2024-332535</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 24 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:69px"></span><span>9</span><span class="cite-subtotal">&middot; +5.29</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Kynurenine — is_biomarker_for → Colorectal cancer stage</span><span class="cite-claim-weight">+1.29</span><a href="../claim/15709a5e8bd22547.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">20 potential metabolite biomarkers panel — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/33fe4093f005b045.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">17 validated metabolite biomarkers — predicts → colorectal cancer prognosis after tumor resection</span><span class="cite-claim-weight">+0.50</span><a href="../claim/c254140a94088a9b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">TTD metabolite panel (8 metabolites) — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/244e9f1f256e747e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">survival risk score (metabolite biomarkers) — predicts → progression-free survival</span><span class="cite-claim-weight">+0.50</span><a href="../claim/7d2632421e928b99.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">TTD metabolites in plasma — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/1079d4ecf1f2ac14.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolites — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/25bc564792710f83.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Hypoxanthine — correlates_with → N-nitrosamine compounds (VNAs)</span><span class="cite-claim-weight">+0.50</span><a href="../claim/d3f520ec50f09a80.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Metabolomics biomarker panel — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/7667e215debaa48d.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:100px"></span><span>13</span><span class="cite-subtotal">&middot; -3.73</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">SWATHtoMRM method — distinguishes → colorectal cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/6a5cfbad44c61df6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">tryptophan — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">-0.58</span><a href="../claim/a42864072a5c69c5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">bile acids — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">-0.40</span><a href="../claim/4013d9365dfef12a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">N-nitrosodimethylamine (NDMA) — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/9b1d2e9a856b32d0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">N-nitrosopyrrolidine (NPYR) — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/bbb12c34554e41aa.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Hypoxanthine — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/c6afee54edf77805.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">11,12-epoxy-(5Z,8Z,11Z)-icosatrienoic acid — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/8141a9b4256255c4.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">16(R)-HETE — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/b326b7b5e0ffec39.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Acetylcarnitine — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/57435cc0143ff974.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lysophosphatidic acid LPA 20:5 — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/2650d605437a178d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lysophosphatidic acid LPA 20:4 — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/8e538235901b3034.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">N-nitrosodimethylamine (NDMA) — correlates_with → Colorectal Cancer progression</span><span class="cite-claim-weight">-0.25</span><a href="../claim/d0b01d81705b3694.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">N-nitrosopyrrolidine (NPYR) — correlates_with → Colorectal Cancer progression</span><span class="cite-claim-weight">-0.25</span><a href="../claim/0edc02bc9213e0ec.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:15px"></span><span>2</span><span class="cite-subtotal">&middot; +1.55</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">survival risk score (metabolite biomarkers) — predicts → overall survival</span><span class="cite-claim-weight">+0.60</span><a href="../claim/59a7e5675693b138.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Adenosine 5&#x27;-monophosphate (AMP) — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/dfc92938c145f5b4.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>49de0da24823e6e9</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/CHEBI:17636">CHEBI:17636</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
